Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemiaLinde Dekker, Stefan Nierkens, Peter M. Hoogerbrugge et al.|Blood Advances|2022Cited by 89
MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistanceJordy C.G. van der Zwet, Jules P.P. Meijerink, Jessica G. C. A. M. Buijs-Gladdines et al.|Leukemia|2021Cited by 48
S255: EFFICACY AND SAFETY OF TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) MATURE B-CELL NON-HODGKIN LYMPHOMA (NHL): THE PHASE II BIANCA STUDYVéronique Minard‐Colin, Birgit Burkhardt, Jochen Buechner et al.|HemaSphere|2022Cited by 5
The Central Role of MAPK-ERK Signaling in IL7-Dependent and IL7-Independent Steroid Resistance Reveals a Broad Application of MEK-Inhibitors Compared to JAK1/2-Inhibition in T-ALLJordy C.G. van der Zwet, Jules P.P. Meijerink, Jessica G. C. A. M. Buijs-Gladdines et al.|Blood|2020Cited by 2